Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 16 Cholangiocarcinoma 8 Barrett Esophagus 6 Thyroid Neoplasms 5 Recurrence 5 Pancreatic Neoplasms 5 Liver Neoplasms 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Breast Neoplasms 4 Thyroid Nodule 3 Esophageal Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Prostatic Neoplasms 2 Pain 2 Neoplasms 2 Hyperaldosteronism 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Agnosia 2 Squamous Intraepithelial Lesions 1 Rectal Neoplasms 1 Papillary Thyroid Microcarcinoma 1 Pancreatic cancer, adult 1 Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1 Neuroma 1 Neuralgia 1

Interventions

Uterine Myomectomy 3 Terlipressin 3 Sodium Chloride 3 Vasopressins 2 Uterine Artery Embolization 2 testo 1 carbetocin 1 Saline Solution 1 Radiofrequency Ablation 1 Magnesium Sulfate 1 Hysteroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Myoma × Radiofrequency Ablation × Clear all

NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed

Leiomyoma, Menorrhagia, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡